Atrás
Rango del Día
$28.30
$29.25
Rango de 52 Semanas
$12.47
$37.35
Volumen
8,201,951
Promedio 50D / 200D
$32.63
/
$23.84
Cierre Anterior
$28.77
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 24.1 | 0.4 |
| P/B | 4.3 | 2.9 |
| ROE % | 21.2 | 3.9 |
| Net Margin % | 8.2 | 3.8 |
| Rev Growth 5Y % | 2.1 | 10.0 |
| D/E | 2.2 | 0.2 |
Precio Objetivo de Analistas
Hold
$38.33
+31.5%
Low: $35.00
High: $41.00
P/E Futuro
10.6
EPS Futuro
$2.70
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
17 B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$4.06
$4.01 – $4.12
|
19 B | 1 |
| FY2029 |
$3.58
$3.54 – $3.64
|
18 B | 1 |
| FY2028 |
$3.44
$2.25 – $4.45
|
18 B | 3 |
Puntos Clave
Revenue grew 2.10% annually over 5 years — modest growth
ROE of 21.23% indicates high profitability
Debt/Equity of 2.20 — high leverage
Generating 1.15B in free cash flow
Cash machine — converts 81.42% of earnings into free cash flow
Capital efficient — spends only 2.90% of revenue on capex
Crecimiento
Revenue Growth (5Y)
2.10%
Revenue (1Y)4.31%
Earnings (1Y)N/A
FCF Growth (3Y)16.77%
Calidad
Return on Equity
21.23%
ROIC6.40%
Net Margin8.17%
Op. Margin12.50%
Seguridad
Debt / Equity
2.20
Current Ratio1.04
Interest Coverage2.35
Valoración
P/E Ratio
24.07
P/B Ratio4.29
EV/EBITDA22.14
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4.31% | Revenue Growth (3Y) | 4.36% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 2.10% | Earnings Growth (5Y) | 35.60% |
| Profitability | |||
| Revenue (TTM) | 17.26B | Net Income (TTM) | 1.41B |
| ROE | 21.23% | ROA | 3.46% |
| Gross Margin | 51.79% | Operating Margin | 12.50% |
| Net Margin | 8.17% | Free Cash Flow (TTM) | 1.15B |
| ROIC | 6.40% | FCF Growth (3Y) | 16.77% |
| Safety | |||
| Debt / Equity | 2.20 | Current Ratio | 1.04 |
| Interest Coverage | 2.35 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 24.07 | P/B Ratio | 4.29 |
| P/S Ratio | 1.97 | PEG Ratio | -0.14 |
| EV/EBITDA | 22.14 | Dividend Yield | 0.00% |
| Market Cap | 33.94B | Enterprise Value | 47.76B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 17.26B | 16.54B | 15.85B | 14.93B | 15.88B |
| Net Income | 1.41B | -1.64B | -559.00M | -2.45B | 417.00M |
| EPS (Diluted) | 1.20 | -1.45 | -0.50 | -2.20 | 0.38 |
| Gross Profit | 8.94B | 8.06B | 7.65B | 6.97B | 7.59B |
| Operating Income | 2.16B | -303.00M | 433.00M | -2.20B | 1.72B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 40.75B | 39.33B | 43.48B | 44.01B | 47.67B |
| Total Liabilities | 32.83B | 33.61B | 35.35B | 35.41B | 36.42B |
| Shareholders' Equity | 7.91B | 5.37B | 7.51B | 7.80B | 10.28B |
| Total Debt | 17.38B | 18.08B | 20.15B | 21.56B | 23.46B |
| Cash & Equivalents | 3.56B | 3.30B | 3.23B | 2.80B | 2.17B |
| Current Assets | 13.95B | 12.55B | 12.49B | 12.05B | 12.57B |
| Current Liabilities | 13.46B | 12.80B | 12.25B | 11.47B | 11.03B |